iifl-logo

Gland Pharma Ltd Historical Data

Add as a Preferred Source on Google
1,851
(0.10%)
Feb 6, 2026|12:00:00 AM

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Gland Pharma Ltd Historical Data

09/01/2026calendar-icon
09/02/2026calendar-icon
Date
Open(₹)
High(₹)
Low(₹)
Close(₹)
No. Of Trades(₹)
Total Turnover(₹)
Deliverable Quantity(₹)

07-Jan-2026

1,680.7

1,710.51,680.71,708.412,82415,54,99,769.748,775

08-Jan-2026

1,757.8

1,790.41,6751,694.857,9441,57,80,50,553.61,03,244

09-Jan-2026

1,700

1,7001,672.31,680.611,55015,69,89,279.455,028

12-Jan-2026

1,680.7

1,713.91,657.51,70313,80616,15,43,967.747,698

13-Jan-2026

1,701

1,722.81,699.91,719.25,3296,87,80,772.616,225

14-Jan-2026

1,721.3

1,7601,720.51,753.68,36712,36,39,560.445,563

16-Jan-2026

1,738

1,761.81,6961,704.28,71912,84,65,66539,658

19-Jan-2026

1,704.2

1,712.21,6721,680.99,36811,68,97,009.146,087

20-Jan-2026

1,680.9

1,689.91,650.11,668.915,03617,26,60,481.776,318

21-Jan-2026

1,650

1,7001,6501,692.619,97917,38,93,879.153,172

22-Jan-2026

1,714.8

1,728.11,6931,723.310,2049,28,59,469.434,639

23-Jan-2026

1,719

1,7191,671.31,682.516,72114,37,40,239.720,955

27-Jan-2026

1,683

1,697.21,660.91,675.910,5067,17,99,287.123,111

28-Jan-2026

1,681.8

1,696.81,666.31,689.77,95239,28,44,514.42,05,636

29-Jan-2026

1,824.9

1,847.11,745.71,800.11,48,5365,55,94,35,581.54,53,432

30-Jan-2026

1,800.1

1,874.81,7821,846.632,61184,27,43,587.71,35,098

01-Feb-2026

1,853.7

1,868.61,782.21,834.38,51312,28,50,532.519,679

02-Feb-2026

1,815.8

1,9221,798.61,897.531,75148,52,00,956.91,16,789

03-Feb-2026

1,980

1,984.91,882.91,895.717,87473,11,58,322.62,66,426

04-Feb-2026

1,890

1,904.91,843.11,889.79,23411,02,09,40422,745

05-Feb-2026

1,889.7

1,899.91,845.21,849.26,7058,72,89,468.518,079

Gland Pharma: Related NEWS

Gland Pharma Stock Gains 7% as Q3 Revenue Climbs 22.5% to ₹1,695.3 Crore

The European business reported a 54 percent year on year surge in topline during the quarter.

29 Jan 2026|12:20 PM
Read More
Top Stocks for Today - 8th January 2026

Here are some of the stocks that may see significant price movement today: Infosys, Tata Steel, Cipla Limited, etc.

8 Jan 2026|07:31 AM
Read More
Top Stocks for Today - 4th November 2025

Here are some of the stocks that may see significant price movement: Bharti Airtel, Cipla, Gland Pharma, etc.

4 Nov 2025|08:01 AM
Read More
Top Stocks for Today - 14th July 2025

Here are some of the stocks that may see significant price movement today: Avenue Supermarts, BEML, Gland Pharma, etc.

14 Jul 2025|06:30 AM
Read More
Gland Pharma Gets USFDA Clearance for Visakhapatnam Facility

The receipt of the EIR marks the formal closure of the US health regulator’s pre-approval inspection, which was conducted between February 19 and February 25, 2025.

25 Jun 2025|12:07 PM
Read More
Top Stocks for Today - 5th June 2025

Here are some of the stocks that may see significant price movement today: Hindustan Aeronautics, Gland Pharma, REC, etc.

5 Jun 2025|07:53 AM
Read More
Gland Pharma gets USFDA approval for blood pressure drug

Gland Pharma also established that its version is bioequivalent and therapeutically equivalent to the reference listed drug.

4 Jun 2025|03:34 PM
Read More
Gland Pharma Q4 Net Profit Declines 3.1% to ₹186.5 Crore; Revenue Down 7.3% YoY

Gland Pharma net profit was at ₹186.5 crore as against ₹192.4 crore in the year-ago quarter of FY24.

22 May 2025|08:49 AM
Read More
Gland Pharma Gets USFDA Nod for Glaucoma Drug

Gland Pharma has secured exclusive rights as the first-to-file sponsor of this generic product. This makes it eligible for 180 days of marketing exclusivity in the US

30 Apr 2025|03:40 PM
Read More
USFDA Issues Three Observations to Gland Pharma's Visakhapatnam Facility

The FDA conducted the pre-approval inspection (PAI) from Feb. 19, 2025, to Feb. 25, 2025, as part of the regulatory process for sterile APIs.

26 Feb 2025|12:22 PM
Read More

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Knowledge Center
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Capital Services Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Loading...

Follow us on

facebooktwitterrssyoutubeinstagramlinkedintelegram

2026, IIFL Capital Services Ltd. All Rights Reserved

ATTENTION INVESTORS

RISK DISCLOSURE ON DERIVATIVES

Copyright © IIFL Capital Services Limited (Formerly known as IIFL Securities Ltd). All rights Reserved.

IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016, BSE Enlistment Number (RA): 5016
ARN NO : 47791 (AMFI Registered Mutual Fund & Specialized Investment Fund Distributor), PFRDA Reg. No. PoP 20092018

ISO certification icon
We are ISO/IEC 27001:2022 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.